Loading…
No business profile yet.
Size Ho Tung Chemical (1714.TW) is a Taiwan Materials company (Chemicals: Specialty) with a market value of $459M, the 472nd largest of 687 Taiwan companies the cockpit tracks. Shares closed at NT$15.50 on 6 Nov 2026.
Performance Over six months the shares gained 67.4%, against -20.0% for the median peer and -3.4% for the Taiwan market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue grew 36.3% over the last twelve months (peer median +8.6%); the operating margin is 9.6% (peer median 1.7%).
Valuation It trades at 0.5× enterprise value to sales against a peer median of 1.2× (2nd cheapest of 21).
Price implies For today's price to make sense, revenue must grow about -17% a year for seven years (Req g). Recent delivered growth is -1%, so the hurdle is -16 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 7.7 points above its cost of capital (5.0% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | NT$30.1B | NT$24.0B | NT$20.6B | NT$20.3B | NT$22.6B |
| Revenue growth | — | +17% | +2% | -10% | — |
| Gross profit | NT$4.18B | NT$2.45B | NT$1.71B | NT$1.84B | NT$1.99B |
| EBITDA | NT$3.39B | NT$1.78B | NT$1.51B | NT$1.34B | NT$1.33B |
| Net income | NT$1.16B | NT$490M | NT$415M | NT$599M | NT$370M |
| Free cash flow | NT$1.18B | NT$802M | NT$1.19B | NT$1.15B | -NT$196M |
| Capital expenditure | NT$373M | NT$313M | NT$255M | NT$383M | NT$488M |
| Total debt | NT$2.98B | NT$3.17B | NT$2.88B | NT$2.95B | NT$3.04B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 1714.TW | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -16.2% | -9.1% | 7th lowest of 21 |
| 6-month return | +67.4% | -20.0% | highest of 21 |
| Distance from 52-week high | -38.0% | -40.3% | 10th highest of 21 |
| Revenue growth (TTM) | +36.3% | +8.6% | 3rd highest of 21 |
| Operating margin | 9.6% | 1.7% | 3rd highest of 21 |
| EV / Sales | 0.5× | 1.2× | 2nd cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | -17.3% | 16.0% | least demanding of 15 |
| Growth delivered (Del g) | -1.5% | +6.4% | 3rd lowest of 15 |
| Hurdle (Req g minus delivered) | -15.8 pp | -0.1 pp | least demanding of 15 |
| ROIC minus cost of capital | +7.7 pp | -3.7 pp | highest of 21 |
| EV / EBITDA | 4.2× | 12.8× | 2nd cheapest of 8 |
| Net debt / EBITDA | -2.1× | 1.0× | 3rd least indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Ho Tung Chemical 1714.TW | Taiwan | $459M | +67% | +36% | 10% | 0.5× | -17.3% | -1.5% |
| FuJian Nox Bellcow 300132.SZ | China | $459M | -37% | +18% | 7% | 1.0× | 3.1% | -10.5% |
| Braskem S.A. Sponsored ADR Pfd BAK | United States | $457M | -70% | -1% | 1% | 0.9× | n/a | n/a |
| Valhi VHI | United States | $456M | +11% | +3% | 1% | 0.6× | 32.2% | +2.3% |
| JSP 7942.T | Japan | $462M | +29% | +14% | 8% | 0.5× | -4.0% | +7.2% |
| Advansix ASIX | United States | $454M | -17% | +8% | -1% | 0.5× | 55.3% | +5.6% |
| Nantong Jiangtian Chemical 300927.SZ | China | $463M | -29% | +51% | 5% | 1.7× | 18.0% | +29.0% |
| Lee & Man Chemical 0746.HK | Hong Kong | $465M | -9% | +3% | 18% | 1.1× | -8.5% | +3.9% |
| Dymatic Chemicals 002054.SZ | China | $465M | -25% | +21% | 8% | 1.7× | -0.8% | +12.9% |
| Kente Catalysts 603120.SS | China | $465M | +6% | +9% | 12% | 3.9× | 18.3% | -8.9% |
| Changhua Chemical Technology 301518.SZ | China | $452M | -45% | +17% | -2% | 1.2× | n/a | n/a |
| Renxin New Material 301395.SZ | China | $445M | -10% | +1% | -6% | 1.4× | n/a | n/a |
| UPC Technology 1313.TW | Taiwan | $445M | +4% | -1% | -23% | 0.2× | -2.6% | +2.5% |
| Shenyang Chemical Industry 000698.SZ | China | $445M | -6% | +18% | 1% | 0.7× | n/a | n/a |
| Shaanxi Xinghua Chemistry 002109.SZ | China | $473M | -39% | +20% | -1% | 1.6× | 2.0% | +13.0% |
| Zhejiang Hisun Biomaterials 688203.SS | China | $473M | +16% | +47% | 4% | 2.5× | 16.5% | +26.6% |
| Qingdao Copton Technology 603798.SS | China | $443M | -36% | -12% | 5% | 2.5× | 28.5% | +0.9% |
| Gujarat Alkalies & Chemicals GUJALKALI.NS | India | $476M | -23% | +7% | 2% | 1.0× | 39.8% | +12.5% |
| Shanghai Huide Science & Technology 603192.SS | China | $476M | -15% | +2% | 3% | 1.0× | 15.5% | +10.5% |
| Tian Jin Bohai Chemical 600800.SS | China | $479M | -37% | -24% | -20% | 1.7× | n/a | n/a |
| Soulbrain 036830.KS | South Korea | $480M | -55% | +16% | -3% | 1.5× | n/a | n/a |